$PCT
PureCycle Technologies, Inc. Stock $pct

$pct Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000183003321000025 Filed on November 10, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$18.24M	$24.49M	$2.232M
YoY Change		997.18%
% of Gross Profit
Research & Development	$310.0K	$330.0K	$171.0K
YoY Change		92.98%
% of Gross Profit
Depreciation & Amortization	$774.0K	$522.0K	$475.0K
YoY Change		9.89%
% of Gross Profit
Operating Expenses	$21.88M	$27.51M	$5.967M
YoY Change	2474.0%	360.97%
Operating Profit
YoY Change
Interest Expense	-$930.0K	$1.843M	$642.0K
YoY Change	-9400.0%	187.07%
% of Operating Profit
Other Income/Expense, Net	$3.417M	$6.529M	-$642.0K
YoY Change		-1116.98%
Pretax Income	-$19.39M	-$20.98M	-$120.0K
YoY Change	2208.57%	17380.83%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$19.39M	-$20.98M	-$6.609M
YoY Change	2208.57%	217.4%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.18	-$0.28
Diluted Earnings Per Share	-$156.0K	-$0.18	-$0.28
COMMON SHARES
Basic Shares Outstanding	125.0M shares	118.3M shares	27.16M shares
Diluted Shares Outstanding		118.3M shares	27.16M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$200.8M	$221.3M	$400.0K
YoY Change	211.29%	55218.75%
Cash & Equivalents	$33.42M	$36.70M	$108.0K
Short-Term Investments	$167.4M	$184.6M
Other Short-Term Assets	$144.6M	$2.793M	$100.0K
YoY Change	144467.0%	2693.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$345.3M	$224.0M	$600.0K
YoY Change	431.81%	37240.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$225.2M	$189.2M
YoY Change	204.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$76.50M
YoY Change
Other Assets	$94.12M	$278.7M	$0.00
YoY Change
Total Long-Term Assets	$319.3M	$467.9M	$76.50M
YoY Change	-6.91%	511.64%
TOTAL ASSETS
Total Short-Term Assets	$345.3M	$224.0M	$600.0K
Total Long-Term Assets	$319.3M	$467.9M	$76.50M
Total Assets	$664.7M	$691.9M	$77.10M
YoY Change	62.92%	797.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.401M	$2.084M	$100.0K
YoY Change	32.42%	1984.0%
Accrued Expenses	$35.53M	$44.39M	$0.00
YoY Change	31.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$38.46M	$54.27M	$100.0K
YoY Change	16.28%	54167.0%
LONG-TERM LIABILITIES
Long-Term Debt	$232.5M	$291.9M	$0.00
YoY Change
Other Long-Term Liabilities	$1.069M	$1.076M	$2.700M
YoY Change	6.9%	-60.15%
Total Long-Term Liabilities	$1.069M	$1.076M	$2.700M
YoY Change	6.9%	-60.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$38.46M	$54.27M	$100.0K
Total Long-Term Liabilities	$1.069M	$1.076M	$2.700M
Total Liabilities	$283.1M	$361.8M	$2.800M
YoY Change	-4.42%	12821.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$157.8M	-$138.4M
YoY Change	95.48%
Common Stock	$128.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$381.5M	$330.1M	$6.835M
YoY Change
Total Liabilities & Shareholders Equity	$664.7M	$691.9M	$77.10M
YoY Change	62.92%	797.47%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$19.39M	-$20.98M	-$6.609M
YoY Change	2208.57%	217.4%
Depreciation, Depletion And Amortization	$774.0K	$522.0K	$475.0K
YoY Change		9.89%
Cash From Operating Activities	-$12.55M	-$7.240M	-$270.0K
YoY Change	125390.0%	2581.48%
INVESTING ACTIVITIES
Capital Expenditures	-$49.24M	-$37.66M
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$16.80M	$15.72M	-$76.50M
YoY Change	-78.04%	-120.55%
Cash From Investing Activities	-$32.44M	-$21.94M	-$76.50M
YoY Change	-142.4%	-71.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-708.0K	160.0K	76.99M
YoY Change	-99.08%	-99.79%
NET CHANGE
Cash From Operating Activities	-12.55M	-7.240M	-270.0K
Cash From Investing Activities	-32.44M	-21.94M	-76.50M
Cash From Financing Activities	-708.0K	160.0K	76.99M
Net Change In Cash	-45.69M	-29.02M	220.0K
YoY Change	9038.6%	-13292.27%
FREE CASH FLOW
Cash From Operating Activities	-$12.55M	-$7.240M	-$270.0K
Capital Expenditures	-$49.24M	-$37.66M
Free Cash Flow	$36.69M	$30.42M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001830033
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2021Q1	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	pct:AccountingStandardsUpdate2020-06
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Business Days Prior To Notice Of Redemption DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodBusinessDaysPriorToNoticeOfRedemption	P3D
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity File Number EntityFileNumber	001-40234
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	PureCycle Technologies, Inc.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2293091
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5950 Hazeltine National Drive,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 650
	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32822
	dei	City Area Code CityAreaCode	877
	dei	Local Phone Number LocalPhoneNumber	648-3565
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	125025204	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36672000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64492000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	184575000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2793000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	446000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	224040000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	64938000	USD
CY2021Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	272879000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	266082000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	5807000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	2890000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	189222000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74067000	USD
CY2021Q3	us-gaap	Assets Assets	691948000	USD
CY2020Q4	us-gaap	Assets Assets	407977000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2084000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1058000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	44385000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26944000	USD
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	7798000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4951000	USD
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	122000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	54267000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	33075000	USD
CY2021Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5000000	USD
CY2020Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	USD
CY2021Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	59670000	USD
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	26477000	USD
CY2021Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	232270000	USD
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	235676000	USD
CY2021Q3	pct	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	9530000	USD
CY2020Q4	pct	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	0	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1076000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1000000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	361813000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	296228000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	468421000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	192381000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138387000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80714000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	330135000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	111749000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	691948000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	407977000	USD
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2687000	USD
CY2020Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3564000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	7228000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	7040000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	330000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	171000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1101000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	528000	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24489000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2232000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	39372000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4518000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	27506000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	5967000	USD
	us-gaap	Operating Expenses OperatingExpenses	47701000	USD
	us-gaap	Operating Expenses OperatingExpenses	12086000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	1843000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	642000	USD
	us-gaap	Interest Expense InterestExpense	5722000	USD
	us-gaap	Interest Expense InterestExpense	1827000	USD
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8369000	USD
CY2020Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	4893000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1775000	USD
CY2021Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	3000	USD
CY2020Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	206000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	100000	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6529000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-642000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10409000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3502000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-20977000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-6609000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-58110000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15588000	USD
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	118255000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118255000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27156000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27156000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95773000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95773000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27156000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27156000	shares
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	89000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-17000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20888000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6609000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-58127000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15588000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	111749000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	239000	USD
CY2021Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	36000	USD
CY2021Q1	pct	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	27900000	USD
CY2021Q1	pct	Stock Issued During Period Value Reverse Recapitalization Net Of Redemptions And Issuance Costs StockIssuedDuringPeriodValueReverseRecapitalizationNetOfRedemptionsAndIssuanceCosts	293966000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2021Q1	pct	Stock Reclassified During Period Value StockReclassifiedDuringPeriodValue	33000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	68000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-26074000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	349241000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	835000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-106000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-11059000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	338911000	USD
CY2021Q3	pct	Adjustment To Additional Paid In Capital Warrants Exercised AdjustmentToAdditionalPaidInCapitalWarrantsExercised	196000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	13611000	USD
CY2021Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1695000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	89000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-20977000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	330135000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2380000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11574000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	417000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-4564000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	9807000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	920000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	173000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-4415000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	6485000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5012000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1963000	USD
CY2020Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	16000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-6609000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	6835000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-58110000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15588000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	14753000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2886000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	4893000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1775000	USD
	us-gaap	Depreciation Depreciation	1507000	USD
	us-gaap	Depreciation Depreciation	1409000	USD
	us-gaap	Accretion Expense AccretionExpense	167000	USD
	us-gaap	Accretion Expense AccretionExpense	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2040000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	pct	Issuance Of Warrants Costs IssuanceOfWarrantsCosts	109000	USD
	pct	Issuance Of Warrants Costs IssuanceOfWarrantsCosts	0	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-395000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	314000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	pct	Increase Decrease In Prepaid Expenses And Other Assets Current IncreaseDecreaseInPrepaidExpensesAndOtherAssetsCurrent	2347000	USD
	pct	Increase Decrease In Prepaid Expenses And Other Assets Current IncreaseDecreaseInPrepaidExpensesAndOtherAssetsCurrent	128000	USD
	pct	Increase Decrease In Prepaid Expenses And Other Assets Noncurrent IncreaseDecreaseInPrepaidExpensesAndOtherAssetsNoncurrent	2917000	USD
	pct	Increase Decrease In Prepaid Expenses And Other Assets Noncurrent IncreaseDecreaseInPrepaidExpensesAndOtherAssetsNoncurrent	100000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-399000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-587000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9554000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	288000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2819000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-739000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	5000000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41958000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10784000	USD
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	88153000	USD
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	2423000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	229183000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	44197000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-273139000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2423000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	314000	USD
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	91000	USD
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	600000	USD
	pct	Payments For Advance To Affiliate Financing PaymentsForAdvanceToAffiliateFinancing	0	USD
	pct	Payments For Advance To Affiliate Financing PaymentsForAdvanceToAffiliateFinancing	2704000	USD
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	91000	USD
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	863000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	196000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	pct	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	298461000	USD
	pct	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	USD
	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock	480000	USD
	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4067000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	155000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17173000	USD
	pct	Payments For Redemption Of Vested Investments PaymentsForRedemptionOfVestedInvestments	36000	USD
	pct	Payments For Redemption Of Vested Investments PaymentsForRedemptionOfVestedInvestments	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	294074000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13165000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21023000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-42000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	330574000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	309551000	USD
	pct	Business Combination Acquisition Related Costs General And Administrative BusinessCombinationAcquisitionRelatedCostsGeneralAndAdministrative	3200000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	108000	USD
	us-gaap	Interest Paid Net InterestPaidNet	845000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1581000	USD
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	25300000	USD
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	USD
	pct	Construction In Progress Expenditures Accrued For But Not Yet Paid ConstructionInProgressExpendituresAccruedForButNotYetPaid	1425000	USD
	pct	Construction In Progress Expenditures Accrued For But Not Yet Paid ConstructionInProgressExpendituresAccruedForButNotYetPaid	1319000	USD
	pct	Construction In Progress Expenditures Owed But Not Yet Paid ConstructionInProgressExpendituresOwedButNotYetPaid	1708000	USD
	pct	Construction In Progress Expenditures Owed But Not Yet Paid ConstructionInProgressExpendituresOwedButNotYetPaid	39000	USD
	pct	Share Repurchase Noncash ShareRepurchaseNoncash	1695000	USD
	pct	Share Repurchase Noncash ShareRepurchaseNoncash	0	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	1680000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	4604000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	1961000	USD
	us-gaap	Notes Issued1 NotesIssued1	0	USD
	us-gaap	Notes Issued1 NotesIssued1	1247000	USD
CY2021Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	25000000	shares
CY2021Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	250000000	USD
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Shares Maximum Issued DerivativeInstrumentContingentConsiderationLiabilitySharesMaximumIssued	4000000	shares
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	2000000	shares
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriod	P6M
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Stock Price Trigger DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodStockPriceTrigger	18.00
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Days DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays	20	employee
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Day Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod	30	employee
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Net ReverseRecapitalizationMergerConsiderationNet	1156900000	USD
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	2000000	shares
CY2021Q1	pct	Adjustments To Additional Paid In Capital Recapitalization Transaction Costs AdjustmentsToAdditionalPaidInCapitalRecapitalizationTransactionCosts	27900000	USD
CY2021Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	4600000	USD
CY2021Q1	pct	Business Combination Acquisition Related Costs Advisory Legal And Accounting BusinessCombinationAcquisitionRelatedCostsAdvisoryLegalAndAccounting	5200000	USD
CY2021Q1	pct	Reverse Recapitalization Number Of Shares Transferred In Merger ReverseRecapitalizationNumberOfSharesTransferredInMerger	83500000	shares
CY2021Q1	pct	Reverse Recapitalization Shares Transferred In Merger Price Per Share ReverseRecapitalizationSharesTransferredInMergerPricePerShare	10.00
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Transferred ReverseRecapitalizationMergerConsiderationTransferred	835000000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Revenue Bonds ReverseRecapitalizationMergerConsiderationRevenueBonds	249600000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Convertible Notes ReverseRecapitalizationMergerConsiderationConvertibleNotes	60000000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Line Of Credit ReverseRecapitalizationMergerConsiderationLineOfCredit	314000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Related Party Promissory Note ReverseRecapitalizationMergerConsiderationRelatedPartyPromissoryNote	12000000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Net ReverseRecapitalizationMergerConsiderationNet	1156914000	USD
	pct	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	76510000	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000000	USD
	pct	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	28049000	USD
	pct	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	298461000	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in prior periods have been reclassified to conform with the report classifications of the nine months ended September 30, 2021, noting the Company has reflected the reverse recapitalization pursuant to the Business </span></div>Combination, as well as immaterial corrections related to prior periods for all periods presented within the unaudited condensed consolidated balance sheets, statements of comprehensive loss, statements of stockholders’ equity, and statements of cash flows.
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36700000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64500000	USD
CY2021Q3	pct	Working Capital WorkingCapital	169800000	USD
CY2020Q4	pct	Working Capital WorkingCapital	31900000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138400000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80700000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-58100000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15600000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	26599000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	192381000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80714000	USD
CY2021Q3	pct	Reverse Recapitalization Conversion Price Quotient ReverseRecapitalizationConversionPriceQuotient	1000	USD
CY2021Q3	pct	Reverse Recapitalization Conversion Price Equity Value Threshold ReverseRecapitalizationConversionPriceEquityValueThreshold	775000000	USD
CY2021Q3	pct	Reverse Recapitalization Conversion Price Equity Value Threshold ReverseRecapitalizationConversionPriceEquityValueThreshold	775000000	USD
CY2021Q3	pct	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	6.93
CY2021Q3	pct	Reverse Recapitalization Conversion Shares ReverseRecapitalizationConversionShares	8900000	shares
CY2020Q4	pct	Reverse Recapitalization Conversion Price Quotient ReverseRecapitalizationConversionPriceQuotient	1000	USD
CY2020Q4	pct	Reverse Recapitalization Conversion Price Adjusted Equity Value Percent ReverseRecapitalizationConversionPriceAdjustedEquityValuePercent	0.80
CY2020Q4	pct	Feedstock Supply Agreement Number Of Suppliers FeedstockSupplyAgreementNumberOfSuppliers	1	supplier
CY2020Q4	pct	Feedstock Supply Agreement Number Of Purchasers FeedstockSupplyAgreementNumberOfPurchasers	2	purchaser
CY2021Q3	pct	Common Stock Number Of Votes For Each Share Held CommonStockNumberOfVotesForEachShareHeld	1	vote
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	118240000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	118240000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	613000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	28900
	pct	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P7Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28900
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y5M15D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5900000	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	11.50
CY2021Q1	pct	Class Of Warrant Or Right Remaining Contractual Term ClassOfWarrantOrRightRemainingContractualTerm	P5Y
CY2021Q1	pct	Class Of Warrant Or Right Redemption Price Of Warrants Or Rights ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights	0.01
CY2021Q1	pct	Class Of Warrant Or Right Redemption Of Warrants Or Rights Written Notice Of Redemption Threshold ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsWrittenNoticeOfRedemptionThreshold	P30D
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Stock Price Trigger DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodStockPriceTrigger	18.00
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Days DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays	20	employee
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Day Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod	30	employee
CY2020Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	78000	USD
CY2021Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	78000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-20977000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-6609000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-58110000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15588000	USD
CY2021Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2020Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	882000	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4833000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20977000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20977000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7491000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7491000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27156000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27156000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95773000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-58110000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-58110000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20421000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20421000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118255000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	118255000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95773000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27156000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27156000	shares
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	193529000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4307000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	189222000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	76867000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2800000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74067000	USD
	us-gaap	Depreciation Depreciation	1500000	USD
	us-gaap	Depreciation Depreciation	1400000	USD
CY2021Q3	us-gaap	Depreciation Depreciation	522000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	475000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	184593000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	20000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	38000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	184575000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	0	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	125538000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	125524000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	0	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	59055000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	59051000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	0	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	184593000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	184575000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
	pct	Debt Securities Held To Maturity Weighted Average Remaining Maturity DebtSecuritiesHeldToMaturityWeightedAverageRemainingMaturity	P0Y10M24D
	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2021Q3	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2020Q3	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2021Q2	pct	Loss Contingency Number Of Class Actions LossContingencyNumberOfClassActions	2	classAction

Files In Submission

Name	View Source	Status
0001830033-21-000025-index-headers.html	Edgar Link	pending
0001830033-21-000025-index.html	Edgar Link	pending
0001830033-21-000025.txt	Edgar Link	pending
0001830033-21-000025-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pct-20210930.htm	Edgar Link	pending
pct-20210930.xsd	Edgar Link	pending
pct-20210930_cal.xml	Edgar Link	unprocessable
pct-20210930_def.xml	Edgar Link	unprocessable
pct-20210930_g1.jpg	Edgar Link	pending
pct-20210930_htm.xml	Edgar Link	completed
pct-20210930_lab.xml	Edgar Link	unprocessable
pct-20210930_pre.xml	Edgar Link	unprocessable
pct-form10xqex311q32021.htm	Edgar Link	pending
pct-form10xqex312q32021.htm	Edgar Link	pending
pct-form10xqex321q32021.htm	Edgar Link	pending
pct-form10xqex322q32021.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCT
PureCycle Technologies, Inc. Stock $pct

2021 Q4 Form 10-Q Financial Statement

#000183003321000025 Filed on November 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCT PureCycle Technologies, Inc. Stock $pct

2021 Q4 Form 10-Q Financial Statement

#000183003321000025 Filed on November 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCT
PureCycle Technologies, Inc. Stock $pct